Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

PepGen Inc. (PEPG)

10.46   -0.21 (-1.97%) 08-18 06:13
Open: 10.51 Pre. Close: 10.67
High: 11.98 Low: 10.12
Volume: 24,547 Market Cap: 247(M)
PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is also developing PGN-EDODM1, an EDO peptide-conjugated PMO for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 11.99 - 12.06 12.06 - 12.12
Low: 9.98 - 10.05 10.05 - 10.11
Close: 10.36 - 10.47 10.47 - 10.57

Technical analysis

as of: 2022-08-17 4:25:49 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 13.5     One year: 15.25
Support: Support1: 9.14    Support2: 7.61
Resistance: Resistance1: 11.56    Resistance2: 13.06
Pivot: 11.11
Moving Average: MA(5): 10.68     MA(20): 11.4
MA(100): 0     MA(250): 0
MACD: MACD(12,26): -0.2     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 19.7     %D(3): 20.9
RSI: RSI(14): 44.5
52-week: High: 13.06  Low: 7.82
Average Vol(K): 3-Month: 94 (K)  10-Days: 19 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ PEPG ] has closed above bottom band by 19.9%. Bollinger Bands are 0% narrower than normal.

Headline News

Tue, 16 Aug 2022
What is the Market's View on PepGen Inc (PEPG) Stock's Price and Volume Trends Tuesday? - InvestorsObserver

Tue, 16 Aug 2022
Partisan Rifts Widen, Perceptions of School Quality Decline - EducationNext

Tue, 16 Aug 2022
Parental Anxieties over Student Learning Dissipate as Schools Relax Anti-Covid Measures - EducationNext

Fri, 12 Aug 2022
2022-08-12 | NDAQ:PEPG | Press Release | PepGen Inc. - Stockhouse

Wed, 10 Aug 2022
PepGen (NASDAQ:PEPG) Shares Down 9.3% - Defense World

Sun, 07 Aug 2022
Agenda set for RSU 71 board meeting Aug. 8 - PenBayPilot.com

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 24 (M)
Shares Float 10 (M)
% Held by Insiders 32 (%)
% Held by Institutions 54.9 (%)
Shares Short 292 (K)
Shares Short P.Month 9 (K)

Stock Financials

EPS -42.35
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -51.46
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) 0
Return on Equity (ttm) -62
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -1.45
Qtrly Earnings Growth 0
Operating Cash Flow -32 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio -0.25
PEG Ratio 0
Price to Book value -0.21
Price to Sales 0
Price to Cash Flow -7.72

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.